ArticleMolecular biotechnology2026
Characterization of the YCjN ABC Transporter in Escherichia coli: Role in Maltose and Ethidium Bromide Transport.
Article in Molecular biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
This study investigated the functional role of the ycjN gene in Escherichia coli, hypothesizing that its encoded protein, YcjN, functions as a carbohydrate transporter. Bioinformatics analysis confirmed YcjN as a solute-binding protein (SBP). The construction of a ΔycjN deletion strain revealed that ycjN is not essential for bacterial viability. Ethidium bromide (EB) accumulation and efflux assays demonstrated that both the overexpression strain (E. coli/pET28a-ycjN) and wild-type E. coli exhibited significantly higher intracellular EB fluorescence as compared to null-loaded and defective strains, indicating enhanced substrate uptake capacity. No significant differences in EB efflux rates were observed among the strains, confirming that ycjN encodes an inwardly directed uptake pump. Further experiments using ATPase inhibitors ortho-vanadate and CCCP revealed that the YcjNOPV transporter actively transports substrates via ATP hydrolysis, classifying it as an ATP-binding cassette (ABC) family transporter. Substrate specificity analysis using high-performance liquid chromatography (HPLC) and reducing sugar detection confirmed that YcjNOPV primarily transports maltose while also exhibiting glucoside transport activity. These findings establish the functional role of the ycjN gene in carbohydrate transport and provide a foundation for engineering applications involving ABC transporters.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.